Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 173 | 197 | 73 | 11 | 0 |
| Gross Profit | 173 | 197 | 73 | 10 | 0 |
| Operating Expenses | 7,674 | 8,186 | 9,609 | 10,970 | 9,840 |
| Operating Income | -7,501 | -7,989 | -9,536 | -10,959 | -9,840 |
| Interest Expense | 0 | 0 | 0 | -3,890 | 2,870 |
| Other Income | -7,900 | -7,159 | -100 | 11,159 | 1,090 |
| Pre-tax Income | -15,401 | -15,148 | -9,636 | 4,090 | -11,620 |
| Income Tax | N/A | N/A | N/A | 110 | 0 |
| Net Income Continuous | -15,401 | -15,148 | -9,636 | 3,995 | -11,629 |
| Net Income Discontinuous | 111 | 49 | -100 | 158 | 292 |
| Net Income | $-15,290 | $-15,099 | $-9,736 | $4,153 | $-11,337 |
| EPS Basic Total Ops | -666.00 | -1,365.00 | -1,359.00 | 600.00 | -2,000.00 |
| EPS Basic Continuous Ops | -671.36 | -1,369.13 | -1,344.80 | 614.62 | -1,971.02 |
| EPS Basic Discontinuous Ops | 4.84 | 4.43 | -13.96 | 24.31 | 49.49 |
| EPS Diluted Total Ops | -666.00 | -1,365.00 | -1,359.00 | 600.00 | -2,000.00 |
| EPS Diluted Continuous Ops | -671.36 | -1,369.13 | -1,344.80 | 614.62 | -1,971.02 |
| EPS Diluted Discontinuous Ops | 4.84 | 4.43 | -13.96 | 24.31 | 49.49 |
| EBITDA(a) | $-7,507 | $-7,817 | $-9,610 | $-12,819 | $-7,910 |